## Core Concept
The management of enuresis, also known as nocturnal enuresis or bedwetting, involves behavioral therapy and, in some cases, pharmacological interventions. When behavioral therapy fails, the next step is to consider medication that can help manage the condition. The primary goal of pharmacological treatment is to reduce the frequency of enuresis.

## Why the Correct Answer is Right
The correct answer, **D. Desmopressin**, is a synthetic analogue of vasopressin (antidiuretic hormone, ADH). Desmopressin works by increasing water reabsorption in the kidneys, thereby reducing urine production at night. It is specifically indicated for the treatment of nocturnal enuresis when behavioral therapy has failed. Desmopressin has a targeted mechanism of action that directly addresses the underlying issue of excessive nocturnal urine production, which is a common factor in enuresis.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is not provided, but typically, incorrect options might include medications not primarily used for enuresis or those with different mechanisms of action not directly beneficial for this condition.
- **Option B:** This option is also not provided, but if it were a medication like an anticholinergic, it might be used for overactive bladder or certain types of incontinence but is not the first choice for enuresis.
- **Option C:** Similarly, without the specific medication listed, if it were something like a diuretic, it would actually worsen enuresis by increasing urine production.

## Clinical Pearl / High-Yield Fact
A key point to remember is that desmopressin is particularly useful for treating nocturnal enuresis because it decreases nocturnal urine production. It's often recommended to try a therapeutic trial of desmopressin for a limited period (e.g., 3-6 months) to assess efficacy. Additionally, fluid intake should be restricted in the evening when using desmopressin to maximize its effectiveness.

## Correct Answer Line
**Correct Answer: D. Desmopressin.**